全球人工器官市场规模：依器官类型、竞争状况、区域状况、预测

人造器官市场规模及预测

2024 年人造器官市场规模价值为 209.3 亿美元，预计到 2032 年将达到 355.6 亿美元，2026 年至 2032 年的复合年增长率为 7.56%。

人造器官市场的扩张得益于生物人工器官製造、标准化和自动化等生产方法技术的不断进步。本研究报告对全球人造器官市场进行了全面评估，深入分析了关键细分市场、趋势、驱动因素、限制因素、竞争格局以及其他重要因素。

定义全球人造器官市场

人工器官是植入或整合到体内，用于复製或增强器官自然功能的医疗设备。人工器官主要包括可植入装置，例如全人工心臟和心律调节器，以及器官支持装置，例如透析设备和体外膜氧合 (ECMO) 机。人工器官通常由单一人体干细胞形成，然后在实验室中培养。人工器官主要由已与接受者自身干细胞一起培养的塑胶製成，因此人体免疫系统不会排斥该人工器官。

全球人造器官市场概况

生产流程技术的不断发展，包括生物人工器官的製造、标准化和自动化，是市场扩张的主要驱动力。由于糖尿病、心臟病和慢性肾臟病等严重的健康问题，器官衰竭在老年人中变得越来越普遍。此外，车祸造成的受伤和截肢也越来越频繁，增加了对替代器官的需求。

随着医疗技术的进步以及社会对升级现有医疗基础设施的意识不断增强，先进的人工辅助系统也应运而生。 3D生物列印技术的发展以及融入人工智慧（AI）的人工设备的製造也改善了市场前景。另一方面，人工器官市场的成长受到移植价格上涨的限制。然而，器官捐赠者的短缺以及在需要时难以找到捐赠者的问题，正在推动全球人工器官技术的发展。

目录

第一章 全球人工器官市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球人工器官市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章 全球人工器官市场（依器官类型）

• 概述
• 人工心臟
• 人工肾
• 人工胰臟
• 人工肺
• 人工电子耳
• 其他的

6. 全球人造器官市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第七章全球人工器官市场竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第八章 公司简介

• Boston Scientific Corporation
• Berlin Heart GmbH
• Baxter International Inc.
• Edward Lifesciences Corporation
• Carmat SA
• B. Braun Melsungen AG
• Asahi Kasei Medical Co. Ltd
• Abiomed
• Getinge AB
• Medtronic PLC

第九章 附录

• 相关调查

Artificial Organs Market Size And Forecast

Artificial Organs Market size was valued at USD 20.93 Billion in 2024 and is projected to reach USD 35.56 Billion by 2032, growing at a CAGR of 7.56% from 2026 to 2032.

The expansion of the Artificial Organs Market is being driven by rising technological advancements in production methods including bioartificial organ manufacturing, standardization, and automation. The market is comprehensively evaluated in the study on the global Artificial Organs Market. The research provides a thorough analysis of the market's key segments, trends, drivers, restraints, competitive environment, and other important elements.

Global Artificial Organs Market Definition

Artificial organs are medical devices that are implanted or integrated into the body to replicate or enhance the natural functioning of an organ. Artificial organs primarily include implantable devices such as entirely artificial hearts and pacemakers and organ support devices such as dialysis machines and extracorporeal membrane oxygenation (ECMO) devices. Artificial organs are usually formed from individual human stem cells and later cultured in the laboratory. They are mainly composed of plastics in stem cells from transplant recipients who have colonized them. Therefore, the body's immune system does not reject artificial organs.

Global Artificial Organs Market Overview

Growing technological developments in production processes like the creation of bioartificial organs, standardization, and automation are the main reasons fueling the market's expansion. Organ failure is becoming more common among the elderly as a result of significant health issues such as diabetes, heart disease, and chronic renal disease. The need for replacement organs is also growing as injuries from auto accidents and amputations happen more frequently.

Advanced artificial support systems have also been created as a result of improvements in medical technology and increased public awareness of the need to upgrade current medical infrastructure. The development of 3D bioprinting and the production of artificial gadgets by incorporating artificial intelligence (AI) has also improved market prospects. On the other side, the market expansion for artificial organs is constrained by high transplant prices. However, the lack of organ donors and the difficulty in finding them when needed is what is propelling the global development of artificial organ technology.

Global Artificial Organs Market Segmentation Analysis

The Global Artificial Organs Market is segmented based on Organ Type and Geography.

Artificial Organs Market, By Organ Type

• Artificial Heart
• Artificial Kidney
• ArtificialPancreas
• Artificial Lungs
• Artificial Cochlear Implants
• Others

Based on Organ Type, the market is segmented into Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Lungs, Artificial Cochlear Implants, and Others. Due to the rising mortality rate associated with dialysis and the rising demand for artificial kidneys, which is the factor driving the global growth of the Artificial Organs Market, the Artificial Kidney sector commands a sizable market share.

Artificial Organs Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Artificial Organs Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region holds a large number of shares in the market because of the increasing number of chronic diseases, the growing organ transplant acceptance, and the increase in the adoption of advanced technology in the region, which is the factor that boosts the market growth of the Artificial Organs Market.

Key Players

The "Global Artificial Organs Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Boston Scientific Corporation, Berlin Heart GmbH, Baxter International Inc., Edward Lifesciences Corporation, Carmat SA, B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd, Abiomed, Getinge AB, and Medtronic PLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ARTIFICIAL ORGANS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ARTIFICIAL ORGANS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ARTIFICIAL ORGANS MARKET, BY ORGAN TYPE

• 5.1 Overview
• 5.2 Artificial Heart
• 5.3 Artificial Kidney
• 5.4 Artificial Pancreas
• 5.5 Artificial Lungs
• 5.6 Cochlear Implants
• 5.7 Others

6 GLOBAL ARTIFICIAL ORGANS MARKET, BY GEOGRAPHY

• 6.1 Overview
• 6.2 North America
  • 6.2.1 U.S.
  • 6.2.2 Canada
  • 6.2.3 Mexico
• 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 U.K.
  • 6.3.3 France
  • 6.3.4 Rest of Europe
• 6.4 Asia Pacific
  • 6.4.1 China
  • 6.4.2 Japan
  • 6.4.3 India
  • 6.4.4 Rest of Asia Pacific
• 6.5 Rest of the World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 GLOBAL ARTIFICIAL ORGANS MARKET COMPETITIVE LANDSCAPE

• 7.1 Overview
• 7.2 Company Market Ranking
• 7.3 Key Development Strategies

8 COMPANY PROFILES

• 8.1 Boston Scientific Corporation
  • 8.1.1 Overview
  • 8.1.2 Financial Performance
  • 8.1.3 Product Outlook
  • 8.1.4 Key Developments
• 8.2 Berlin Heart GmbH
  • 8.2.1 Overview
  • 8.2.2 Financial Performance
  • 8.2.3 Product Outlook
  • 8.2.4 Key Developments
• 8.3 Baxter International Inc.
  • 8.3.1 Overview
  • 8.3.2 Financial Performance
  • 8.3.3 Product Outlook
  • 8.3.4 Key Developments
• 8.4 Edward Lifesciences Corporation
  • 8.4.1 Overview
  • 8.4.2 Financial Performance
  • 8.4.3 Product Outlook
  • 8.4.4 Key Developments
• 8.5 Carmat SA
  • 8.5.1 Overview
  • 8.5.2 Financial Performance
  • 8.5.3 Product Outlook
  • 8.5.4 Key Developments
• 8.6 B. Braun Melsungen AG
  • 8.6.1 Overview
  • 8.6.2 Financial Performance
  • 8.6.3 Product Outlook
  • 8.6.4 Key Developments
• 8.7 Asahi Kasei Medical Co. Ltd
  • 8.7.1 Overview
  • 8.7.2 Financial Performance
  • 8.7.3 Product Outlook
  • 8.7.4 Key Developments
• 8.8 Abiomed
  • 8.8.1 Overview
  • 8.8.2 Financial Performance
  • 8.8.3 Product Outlook
  • 8.8.4 Key Developments
• 8.9 Getinge AB
  • 8.9.1 Overview
  • 8.9.2 Financial Performance
  • 8.9.3 Product Outlook
  • 8.9.4 Key Developments
• 8.10 Medtronic PLC
  • 8.10.1 Overview
  • 8.10.2 Financial Performance
  • 8.10.3 Product Outlook
  • 8.10.4 Key Developments

9 Appendix

• 9.1 Related Research